Target intelligence / Profile preview

Bothrops snake venom metalloproteinase (SVMP)

Target
SVMP
Molecular classification
Enzyme, Metalloendopeptidase, Reprolysin (M12B family), Zinc-binding protein
01

Overview

Bothrops snake venom metalloproteinases (SVMPs) are the primary toxic enzymes found in the venom of pit vipers belonging to the Bothrops genus, such as Bothrops asper and Bothrops jararaca (Gutiérrez et al., 2016, Toxins). These zinc-dependent enzymes are classified into the reprolysin family (M12B) and are the chief agents responsible for the local and systemic pathologies observed in snakebite victims, including rapid tissue necrosis, massive hemorrhage, and consumptive coagulopathy (UniProt, 2023). SVMPs function by degrading essential components of the extracellular matrix and vascular basement membrane, such as type IV collagen, laminin, and fibronectin, which leads to capillary rupture and bleeding (PubMed, PMID: 16061020). Beyond their structural degradation roles, they also interfere with the coagulation cascade and platelet function, exacerbating systemic hemorrhage. Therapeutic intervention primarily relies on animal-derived antivenoms that contain neutralizing antibodies, though research is increasingly focused on small-molecule inhibitors like Batimastat and metal chelators that target the catalytic zinc ion to prevent permanent tissue damage (ClinicalTrials.gov, 2024). Understanding the diversity of SVMP classes (P-I to P-III) is critical for developing more effective, broad-spectrum treatments for Bothrops envenomation, which remains a major public health challenge in Latin America (WHO, 2021).

Other names
Snake venom metalloproteinaseReprolysin-like metalloproteinaseHemorrhagic toxinZinc-dependent snake venom metalloproteinaseBothrops venom protease
02

Mechanism of action

Neutralization of enzymatic activity through antibody-mediated sequestration or competitive inhibition of the zinc-dependent catalytic site.

03

Biological functions

ProteolysisExtracellular matrix degradationPro-coagulant activityPlatelet aggregation inhibitionInduction of inflammationBasement membrane degradation
04

Disease associations

Snakebite envenomationHemorrhageTissue necrosisCoagulopathyEdemaInflammation
05

Safety considerations

Anaphylaxis (to antivenom)Serum sicknessOff-target inhibition of human matrix metalloproteinases (MMPs)Musculoskeletal syndrome (associated with broad-spectrum metalloproteinase inhibitors)
06

Interacting drugs

Bothrops antivenom (polyvalent)

5 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Activated partial thromboplastin time (aPTT)Fibrinogen levelD-dimerCreatine kinase (CK)Platelet count

Beyond the preview

Go deeper on Bothrops snake venom metalloproteinase (SVMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bothrops snake venom metalloproteinase (SVMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call